(Q54418800)

English

Efficient immune responses against Intimin and EspB of enterohaemorragic Escherichia coli after intranasal vaccination using the TLR2/6 agonist MALP-2 as adjuvant.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/18675866

Efficient immune responses against Intimin and EspB of enterohaemorragic Escherichia coli after intranasal vaccination using the TLR2/6 agonist MALP-2 as adjuvant. (English)

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/18675866

toll-like receptor

0 references

Escherichia coli

1 reference

based on heuristic

inferred from title

author name string

Angel Cataldi

1

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/18675866

Tetyana Yevsa

2

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/18675866

Daniel A Vilte

3

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/18675866

Kai Schulze

4

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/18675866

Mauricio Castro-Parodi

5

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/18675866

Mariano Larzábal

6

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/18675866

Cristina Ibarra

7

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/18675866

Elsa C Mercado

8

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/18675866

Carlos A Guzmán

9

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/18675866

language of work or name

0 references

publication date

21 September 2008

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/18675866

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/18675866

26

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/18675866

5662-5667

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/18675866

44

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/18675866

Enterohaemorrhagic Escherichia coli in human medicine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.027

7 January 2021

Long-term course and mechanisms of progression of renal disease in hemolytic uremic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.027

7 January 2021

A genetic locus of enterocyte effacement conserved among diverse enterobacterial pathogens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.027

7 January 2021

Intimin-specific immune responses prevent bacterial colonization by the attaching-effacing pathogen Citrobacter rodentium

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.027

7 January 2021

Type III secretion systems: machines to deliver bacterial proteins into eukaryotic cells?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.027

7 January 2021

Cloning and characterization of the eae gene of enterohaemorrhagic Escherichia coli O157:H7

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.027

7 January 2021

A novel EspA-associated surface organelle of enteropathogenic Escherichia coli involved in protein translocation into epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.027

7 January 2021

Protein translocation into host epithelial cells by infecting enteropathogenic Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.027

7 January 2021

Enteropathogenic E. coli (EPEC) transfers its receptor for intimate adherence into mammalian cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.027

7 January 2021

Isotype-specific antibody responses against Escherichia coli O157:H7 locus of enterocyte effacement proteins in adult beef cattle following experimental infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.027

7 January 2021

Decreased shedding of Escherichia coli O157:H7 by cattle following vaccination with type III secreted proteins.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.027

7 January 2021

Plant cell-based intimin vaccine given orally to mice primed with intimin reduces time of Escherichia coli O157:H7 shedding in feces

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.027

7 January 2021

Vaccination of pregnant dams with intimin(O157) protects suckling piglets from Escherichia coli O157:H7 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.027

7 January 2021

Protection against hemorrhagic colitis in an animal model by oral immunization with isogeneic rabbit enteropathogenic Escherichia coli attenuated by truncating intimin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.027

7 January 2021

Recombinant Shiga toxin B-subunit-keyhole limpet hemocyanin conjugate vaccine protects mice from Shigatoxemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.027

7 January 2021

Development of a hybrid Shiga holotoxoid vaccine to elicit heterologous protection against Shiga toxins types 1 and 2☆

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.027

7 January 2021

Development of DNA vaccines against hemolytic-uremic syndrome in a murine model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.027

7 January 2021

Genetic toxoids of Shiga toxin types 1 and 2 protect mice against homologous but not heterologous toxin challenge.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.027

7 January 2021

Subunit vaccines based on intimin and Efa-1 polypeptides induce humoral immunity in cattle but do not protect against intestinal colonisation by enterohaemorrhagic Escherichia coli O157:H7 or O26:H-.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.027

7 January 2021

Vaccination of calves with EspA, a key colonisation factor of Escherichia coli O157:H7, induces antigen-specific humoral responses but does not confer protection against intestinal colonisation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.027

7 January 2021

Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentration

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.027

7 January 2021

The Mycoplasma-derived lipopeptide MALP-2 is a potent mucosal adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.027

7 January 2021

The Mycoplasma-derived macrophage-activating 2-kilodalton lipopeptide triggers global immune activation on nasal mucosa-associated lymphoid tissues

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.027

7 January 2021

Detection of Shiga toxin-producing Escherichia coli by PCR in cattle in Argentina. Evaluation of two procedures.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.027

7 January 2021

Non-O157 Shiga toxin-producing Escherichia coli isolated from diarrhoeic calves in Argentina.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.027

7 January 2021

Enhanced protection against Streptococcus pyogenes infection by intranasal vaccination with a dual antigen component M protein/SfbI lipid core peptide vaccine formulation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.027

7 January 2021

Antibodies to intimin and Escherichia coli secreted proteins A and B in patients with enterohemorrhagic Escherichia coli infections

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.027

7 January 2021

Human response to Escherichia coli O157:H7 infection: antibodies to secreted virulence factors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.027

7 January 2021

The HIV-1 matrix protein p17 can be efficiently delivered by intranasal route in mice using the TLR 2/6 agonist MALP-2 as mucosal adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.027

7 January 2021

Efficient systemic and mucosal responses against the HIV-1 Tat protein by prime/boost vaccination using the lipopeptide MALP-2 as adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.027

7 January 2021

The Toll-like receptor ligand MALP-2 stimulates dendritic cell maturation and modulates proteasome composition and activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.027

7 January 2021

Comparison of colonization dynamics and pathology of mice infected with enteropathogenic Escherichia coli, enterohaemorrhagic E. coli and Citrobacter rodentium.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.027

7 January 2021

Serum antibody responses of cattle following experimental infection with Escherichia coli O157:H7

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.027

7 January 2021

based on heuristic

inferred from DOI database lookup

Type III secretion-dependent hemolytic activity of enteropathogenic Escherichia coli

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.07.027

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2008.07.027

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/18675866

1 reference

Europe PubMed Central

29 May 2018

http://europepmc.org/abstract/MED/18675866

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54418800&oldid=1792304949"